Roche weathers tough year and looks to pipeline for 2011
February 3, 2011Research and Development, Sales and Marketing 2010 pharma results, BRAF protein, GDC-0449, RG3616, RG7204, Roche, avastin, pertuzumab
Roche is looking to its innovative late-stage pipeline to help it get back on track for the next financial year …
Blood clot fears halt cancer trial enrolment
February 3, 2011Research and Development BMS, Bristol-Myers Squibb, Eli Lilly, NSCLC, lilly, necitumumab, non small cell lung cancer, non-small cell lung cancer
Lilly and BMS have stopped enrolment in a phase III trial of necitumumab, a new treatment for non-small cell lung …
Jango to manage Grünenthal pain awards
February 3, 2011Medical Communications Grunenthal, Jango, awards, disease awareness campaigns
Jango Communications has been appointed by Grünenthal to manage the Pain Awards Programme they are sponsoring this year. German-based Grünenthal, …
The Project Management Office – Accelerating Project Management Maturity
February 3, 2011Sales and Marketing Kinapse, White paper
Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …
Diabetes success for Sanofi, disappointment for Roche
February 2, 2011Roche, Sanofi, diabetes
The contrasting fortunes of two new diabetes became clear today, with Sanofi-Aventis lixisenatide performing well, as Roche abandoned taspoglutide.Sanofi’s lixisenatide, …
Government seeks to salvage Pfizer site
February 2, 2011Research and Development Pfizer, Sandwich
Science minister David Willetts says the government will do all it can to maintain pharma research in Kent, after Pfizer …
Leading universities sound alarm over UK research
February 2, 2011Research and Development Jobs, Pfizer, Sandwich, universities
Cuts to government funding for research in universities have been condemned by the UK’s top centres of learning. The government …
Cherry Wood new HCA chair
February 1, 2011Medical Communications Cherry Wood, HCA
The Healthcare Communications Association (HCA) has announced that Cherry Wood, managing director of Liberation Communications, has been elected its new …
Pfizer to close UK R&D site
February 1, 2011Research and Development Kent, Pfizer, R&D, Sandwich, closure
Pfizer has announced that it is to close its UK research site at Sandwich in Kent, with the loss of …
GSK settles Avandia case out of court
February 1, 2011Sales and Marketing Avandia, GSK, diabetes
GlaxoSmithKline this week settled a US federal lawsuit regarding its diabetes drug Avandia before it went to court. The company …
FDA process validation guidelines emphasise risk management
February 1, 2011Manufacturing and Production FDA, ICH, process validation
The FDA has published the final version of its Guideline on Process Validation, more than two years after the first …
Sanofi – Genzyme deal edges closer
February 1, 2011Sales and Marketing Genzyme, Lemtrada, Sanofi
Sanofi-Aventis has entered into a confidentiality agreement with Genzyme to discuss the prospects of Lemtrada, which suggests a deal could …
Oxford BioMedica buys decommissioned facility
February 1, 2011Manufacturing and Production Oxford BioMedica, RecipharmCobra Biologics, manufacturing
Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …
Tarceva set for first line treatment
January 31, 2011Sales and Marketing Iressa, NSCLC, Roche, Tarceva
Roche’s lung cancer treatment Tarceva has been shown to help patients as a first line treatment. An independent data monitoring …
UK hails high uptake of cervical cancer vaccine
January 31, 2011Research and Development Cervarix, HPV
The NHS campaign to vaccinate girls against the future risk of developing cervical cancer has been a success, according to …
AstraZeneca revenues reach standstill
January 31, 2011Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results
AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …
GSK and Actelion drop insomnia treatment
January 30, 2011Research and Development Actelion, GSK, insomnia
Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …
Mitsubishi Tanabe recalls two million injectables
January 28, 2011Manufacturing and Production Mitsubishi, injectables, recall
Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …
Mike Paling receives outstanding contribution award
January 28, 2011Medical Communications Mike Paling, TBWA/Paling Walters, awards
Mike Paling, chief executive and chairman of TBWA\Paling Walters has received an award for Outstanding Contribution to Pharmaceutical Marketing for …
EMA road map to prioritise pharmacovigilance
January 28, 2011Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance
The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
